Milton C. Ault III - 23 Dec 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
By: /s/ Milton C. Ault, III, Chief Executive Officer of Ault & Company, Inc.
Issuer symbol
ALZN
Transactions as of
23 Dec 2025
Net transactions value
-$3,825
Form type
4
Filing time
30 Dec 2025, 17:54:03 UTC
Previous filing
23 Dec 2025
Next filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS By: /s/ Milton C. Ault, III, Chief Executive Officer of Ault & Company, Inc. 30 Dec 2025 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale $3,825 -1,851 -100% $2.07 0 23 Dec 2025 Direct F1
holding ALZN Common Stock 8,260 23 Dec 2025 By Ault Lending, LLC F2
holding ALZN Common Stock 11,068 23 Dec 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 61 23 Dec 2025 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such shares were sold at the direction of the reporting person, for purposes of realizing tax losses.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.